The Neogen Corp (NEOG) share price is expected to increase by 7.71% over the next year. This is based on calculating the average 12-month share price estimate provided by 1 stock analysts who have covered NEOG. Price targets range from $19.00 at the low end to $19.00 at the high end. The current analyst consensus for NEOG is a hold. Please note analyst price targets are not guaranteed and could be missed completely.
NEOG is a stock in Health Care which has been forecasted to be worth $19.00 as an average. On the higher end, the forecast price is $19.00 USD by david westenberg from Piper Sandler and on the lower end NEOG is forecasted to be $19.00 by david westenberg from Piper Sandler.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
david westenberg Piper Sandler | Hold | $19.0 | rated | Jan 18, 2024 |
timothy daley Wells Fargo | Buy | $28.0 | maintained | Aug 14, 2023 |
brandon vazquez William Blair | Buy | None | upgraded | Nov 22, 2022 |
gerry sweeney Roth Capital | Hold | $37.5 | maintained | Jul 23, 2020 |
mark connelly Stephens | Buy | $44.0 | reiterated | Jul 14, 2020 |
kevin ellich Craig-Hallum | Buy | $78.0 | reiterated | Jul 24, 2019 |
drew jones Stephens | Hold | $75.0 | reiterated | Oct 3, 2018 |
anton brenner Roth Capital | Buy | $68.0 | reiterated | Sep 28, 2016 |
charles haff Craig-Hallum | Hold | $65.0 | downgraded | Dec 22, 2015 |
brian weinstein William Blair | Hold | None | maintained | Nov 20, 2015 |
paul knight KeyBanc | Hold | $46.0 | rated | Dec 19, 2013 |
steven crowley Craig-Hallum | Hold | None | downgraded | Jul 24, 2013 |
elliott schlang Wellington Shields | Sell | None | downgraded | Jul 24, 2013 |
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
When did it IPO
1989
Staff Count
2,640
Country
United States
Sector/Industry
Healthcare/Diagnostics & Research
CEO
Mr. John Edward Adent
Market Cap
$3.82B
In 2023, NEOG generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that NEOG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
HWC-USD
$43.89
COLB-USD
$18.28
AXSM-USD
$80.47
LOPE-USD
$130.07
EXPO-USD
$76.86
PGNY-USD
$40.78